MX340742B - Compuestos macrociclicos de 18 miembros y analogos de los mismos. - Google Patents

Compuestos macrociclicos de 18 miembros y analogos de los mismos.

Info

Publication number
MX340742B
MX340742B MX2012009525A MX2012009525A MX340742B MX 340742 B MX340742 B MX 340742B MX 2012009525 A MX2012009525 A MX 2012009525A MX 2012009525 A MX2012009525 A MX 2012009525A MX 340742 B MX340742 B MX 340742B
Authority
MX
Mexico
Prior art keywords
opt
analogs
specifically
membered macrocycles
membered
Prior art date
Application number
MX2012009525A
Other languages
English (en)
Inventor
Shue Youe-Kong
Hwang Chan-Kou
Chiu Yu-Hung
Romero Alex
Babakhani Farah
Sears Pamela
Okumu Franklin
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of MX340742B publication Critical patent/MX340742B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/22—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom rings with more than six members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere en general a agentes antimicrobianos macrocíclicos de 18 miembros llamados Tiacumicinas, específicamente, el OPT-80 (que está compuesto casi enteramente de R-Tiacumicina B), a composiciones farmacéuticas que comprenden OPT-80, y a métodos que usan OPT-80. En particular, este compuesto es un fármaco potente para el tratamiento de infecciones bacterianas, específicamente infecciones de C. difficile.
MX2012009525A 2005-01-31 2005-01-31 Compuestos macrociclicos de 18 miembros y analogos de los mismos. MX340742B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2005/002887 WO2006085838A1 (en) 2005-01-31 2005-01-31 18-membered macrocycles and analogs thereof

Publications (1)

Publication Number Publication Date
MX340742B true MX340742B (es) 2016-07-21

Family

ID=36793325

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2007009196A MX2007009196A (es) 2005-01-31 2005-01-31 Compuestos macrocilicos de 18 miembros y analogos de los mismos.
MX2012009525A MX340742B (es) 2005-01-31 2005-01-31 Compuestos macrociclicos de 18 miembros y analogos de los mismos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2007009196A MX2007009196A (es) 2005-01-31 2005-01-31 Compuestos macrocilicos de 18 miembros y analogos de los mismos.

Country Status (10)

Country Link
EP (1) EP1848273A4 (es)
JP (1) JP5166040B2 (es)
KR (1) KR101203118B1 (es)
CN (2) CN102614207B (es)
AU (1) AU2005327308B2 (es)
BR (1) BRPI0519890A2 (es)
CA (1) CA2596387C (es)
MX (2) MX2007009196A (es)
TW (1) TWI306097B (es)
WO (1) WO2006085838A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7906489B2 (en) 2004-05-14 2011-03-15 Optimer Pharmaceuticals, Inc. 18-membered macrocycles and analogs thereof
US7378508B2 (en) * 2007-01-22 2008-05-27 Optimer Pharmaceuticals, Inc. Polymorphic crystalline forms of tiacumicin B
CA2626698C (en) * 2005-10-21 2015-12-01 Optimer Pharmaceuticals, Inc. Method of treating clostridium difficile-associated diarrhea
TWI482772B (zh) * 2006-08-21 2015-05-01 Astrazeneca Ab 適合口服且包含三唑并[4,5-d]嘧啶衍生物之組合物
US20080176927A1 (en) * 2007-01-19 2008-07-24 Optimer Pharmaceuticals, Inc. Compositions of stable tiacumicins
ZA200905337B (en) * 2007-01-22 2010-10-27 Optimer Pharmaceuticals Inc Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof
AU2012244278C1 (en) * 2007-01-22 2014-11-06 Merck Sharp & Dohme Llc Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof
TWI523654B (zh) * 2007-11-27 2016-03-01 默沙東藥廠 抗生素巨環化合物以及其製造及使用之方法
WO2012106722A2 (en) * 2011-02-04 2012-08-09 Optimer Pharmaceuticals, Inc. Treatment of bacterial infections
WO2013170142A1 (en) * 2012-05-10 2013-11-14 Teva Pharmaceutical Works Ltd. Solid state forms of fidaxomycin and processes for preparation thereof
US8722863B2 (en) 2012-05-10 2014-05-13 Teva Pharmaceutical Works Ltd. Solid state forms of fidaxomycin and processes for preparation thereof
JO3464B1 (ar) 2013-01-15 2020-07-05 Astellas Pharma Europe Ltd التركيبات الخاصة بمركبات التياكوميسين
CN103275152B (zh) * 2013-05-29 2015-11-18 华北制药集团新药研究开发有限责任公司 一种高纯度非达霉素的制备方法
JP2017507994A (ja) * 2014-03-18 2017-03-23 クセリア ファーマシューティカルズ エーピーエスＸｅｌｌｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ ＡｐＳ チアクマイシンｂの新たな多形及び新たな固体状態
CN103897003B (zh) * 2014-03-28 2016-07-06 华北制药集团新药研究开发有限责任公司 非达霉素晶型ii及其制备方法
CA2948400A1 (en) 2014-05-09 2015-11-12 Astellas Pharma Europe Ltd Treatment regimen tiacumicin compound
MA42309A (fr) 2015-07-03 2021-03-24 Astellas Pharma Europe Ltd Nouveau composé de tiacumicine pour régime posologique
CN105237599B (zh) * 2015-10-09 2018-10-02 华北制药集团新药研究开发有限责任公司 闰年霉素a4晶体及其制备方法
CN110183502A (zh) * 2019-05-28 2019-08-30 杭州华东医药集团新药研究院有限公司 一种非达霉素杂质及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1458512A (en) * 1973-11-22 1976-12-15 Lepetit Spa Antibiotic substance
US4918174A (en) * 1986-09-26 1990-04-17 Abbott Laboratories Tiacumicin compounds
US5583115A (en) * 1995-05-09 1996-12-10 Abbott Laboratories Dialkyltiacumicin compounds
US5767096A (en) * 1996-07-12 1998-06-16 Abbott Laboratories Bromotiacumicin compounds
CA2494742C (en) * 2002-07-29 2015-05-12 Optimer Pharmaceuticals, Inc. Tiacumicin production
PL2305245T3 (pl) * 2004-05-14 2019-05-31 Merck Sharp & Dohme Leczenie chorób związanych ze stosowaniem antybiotyków (poantybiotykowych)

Also Published As

Publication number Publication date
TWI306097B (en) 2009-02-11
CN101128114B (zh) 2012-03-28
TW200626585A (en) 2006-08-01
CN101128114A (zh) 2008-02-20
EP1848273A4 (en) 2010-02-24
CA2596387C (en) 2012-11-20
EP1848273A1 (en) 2007-10-31
AU2005327308B2 (en) 2011-11-10
AU2005327308A1 (en) 2006-08-17
JP5166040B2 (ja) 2013-03-21
KR101203118B1 (ko) 2012-11-20
CN102614207B (zh) 2016-01-13
MX2007009196A (es) 2009-02-25
JP2008528582A (ja) 2008-07-31
KR20070110504A (ko) 2007-11-19
CA2596387A1 (en) 2006-08-17
WO2006085838A1 (en) 2006-08-17
BRPI0519890A2 (pt) 2009-03-31
CN102614207A (zh) 2012-08-01

Similar Documents

Publication Publication Date Title
TW200626585A (en) 18-membered macrocycles and analogs thereof
EP2041159B8 (en) Macrocyclic compounds as antiviral agents
MX2009005603A (es) Compuestos de urea policiclicos antibacterianos.
TW200640908A (en) Chemical compounds
NO20073764L (no) Sammensetninger for behandling av HCV
WO2004062601A3 (en) Antibacterial agents
SG153833A1 (en) Methods of treatment of endobronchial infections
MY150958A (en) Compounds for the treatment of multi-drug resistant bacterial infections
WO2008154642A3 (en) Antibacterial agents
WO2006017295A3 (en) Tetrapeptide analogs
TW200734344A (en) Antibacterial agents
MX2009008540A (es) Inhibidores de virus de hepatitis c macrociclicos sustituidos con pirimidina.
MX2009008541A (es) Fenilcarbamatos macrociclicos que inhiben el virus de hepatitis c.
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
UA95644C2 (ru) Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний
WO2008020229A3 (en) Antibacterial pyrrolecarboxamides
WO2008020227A3 (en) Antibacterial pyrrolecarboxamides
TW200745062A (en) Macrocyclic factor VIIA inhibitors useful as anticoagulants
WO2007071965A3 (en) Antibacterial pyrrolopyridines, pyrrolopyrimidines, and pyrroloazepines
AP2003002942A0 (en) New derivatives of oxazolidinones as bacterial agents
SI1817326T1 (sl) Industrijski postopek za pripravo gama-laktona 17-hidroksi-6-beta, 7-beta, 15-beta, 16-beta-bismetilen-3-okso 17-alfa pregn-4-en-21- karboksilne kisline in kljuäśni intermediati za ta postopek
WO2006078724A3 (en) Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases
WO2009116044A3 (en) Guanine nucleotide derivatives for treating bacterial infections
UY28542A1 (es) Amidas macrocíclicas antibacterianas
TW200716618A (en) Chemical compounds